|4Jan 4, 3:59 PM ET

Bernard Thierry 4

4 · T2 Biosystems, Inc. · Filed Jan 4, 2022

Insider Transaction Report

Form 4
Period: 2022-01-01
Transactions
  • Award

    Restricted Stock Units

    2022-01-01+77,51977,519 total
    Common Stock (77,519 underlying)
  • Exercise/Conversion

    Common Stock

    2022-01-01+32,25854,985 total
  • Exercise/Conversion

    Restricted Stock Units

    2022-01-01+32,2580 total
    Common Stock (32,258 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]On January 1, 2021 the reporting person was granted 32,258 restricted stock units that vested on January 1, 2022.
  • [F3]The restricted stock units were granted in accordance with the Issuer's Non-Employee Director Compensation Plan and vest on January 1, 2023.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION